| Application | Recommended Dilution |
|---|---|
| ELISA | 1:5000-1:50000 |
Connective tissue growth factor, also designated CCN2, serves as a critical matricellular protein orchestrating diverse biological processes including fibrosis, wound healing, angiogenesis, and extracellular matrix remodeling. This secreted protein plays particularly significant roles in cardiovascular pathophysiology and immune regulation, where its dysregulation has been implicated in fibrotic diseases affecting multiple organ systems. Understanding CTGF signaling pathways remains essential for researchers investigating tissue repair mechanisms and developing therapeutic strategies targeting fibrotic conditions.
This recombinant monoclonal antibody against CTGF offers researchers the reproducibility advantages inherent to sequence-defined antibody production. Unlike traditional hybridoma-derived antibodies, recombinant technology ensures consistent performance across lots, eliminating the variability that can compromise longitudinal studies or multi-site collaborations. The defined genetic sequence underlying clone 5C12 provides confidence that your experimental conditions will translate reliably from pilot experiments through publication-ready data.
Functional ELISA validation demonstrates robust binding characteristics across species, supporting investigations in both human and non-human primate models. Testing against immobilized human CTGF protein revealed an EC50 range of 0.5470–0.7308 ng/mL, while evaluation with rhesus macaque CTGF yielded comparable sensitivity with an EC50 of 0.6886–0.7825 ng/mL. This cross-species reactivity with Macaca fascicularis proves valuable for translational research requiring primate model systems. For ELISA applications, dilutions ranging from 1:5000 to 1:50000 provide flexibility to optimize signal-to-noise ratios across different experimental conditions.
Supplied as an affinity-purified human IgG1 in a glycerol-stabilized PBS formulation, this antibody supports cardiovascular and immunology research programs investigating CTGF-mediated signaling in fibrotic disease, tissue remodeling, and related pathological processes.
Email: support@cusabio.com
Distributors Worldwide